Retracted study highlights importance of peer review in cannabis research
RETRACTED: Masataka, N. Possible Anxiolytic Effects of Cannabidiol (CBD) Administration on Feline Responses to a Fear Response Test. Animals 2025, 15, 1642.
AI Summary
This research article has been retracted by the journal and should not be relied upon as valid scientific evidence. The paper originally proposed to investigate potential anxiolytic (anxiety-reducing) effects of cannabidiol (CBD) in cats using a fear response test. However, the retraction means the findings, methodology, or data integrity were deemed insufficient or problematic by the publisher and scientific community.
Retracted studies are removed from the scientific record because they no longer meet standards for reliability and accuracy. This retraction is significant for anyone interested in CBD research, as it demonstrates the peer review and quality control systems at work in cannabis science. Readers should be cautious about citing or relying on this research, and instead look to studies that remain published and have withstood scrutiny.
For those researching CBD and anxiety—whether in animals or humans—this retraction highlights the importance of consulting current, peer-reviewed research from reputable sources. The scientific community is actively working to ensure that cannabis research meets rigorous standards of quality and reproducibility.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Anxiety research papers you might find interesting.
Review finds promise in acidic cannabinoids, but human benefits remain unproven
Review finds promising but variable CBD evidence in dogs and cats
Spain survey finds cannabis use spans sex, stress and sleep
Explore More Research
Stay informed about the latest cannabis science.